ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
Dow Jones
41.938,45
-1,63%
Euro vs US Dollar
1,02545
0,00%
Bitcoin
94.242,73
-0,35%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Brainstorm Cell Therapeutics Inc (BCLI)

  7. Brainstorm Cell Therapeutics Inc (BCLI) News

BCLI

Brainstorm Cell Therapeu... (BCLI)

Brainstorm Cell Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BCLI
DatumZeitQuelleÜberschriftSymbolFirma
07/01/202522h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
07/01/202522h10Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
03/01/202523h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422h40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/11/202421h24Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
13/11/202413h55Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
30/10/202413h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
02/10/202414h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
01/10/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
01/10/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
30/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
26/09/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
24/09/202422h30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
17/09/202421h32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/09/202422h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
09/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
28/08/202423h01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413h03Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
16/08/202413h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCLIBrainstorm Cell Therapeutics Inc
14/08/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCLIBrainstorm Cell Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BCLI

Kürzlich von Ihnen besucht

COIN
AVAXUSD
Avalanche
COIN
XRPUSD
Ripple
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
CCOM
US30
US 30
NYSE
DIS
Walt Disney
DBI
TDXP
Tec DAX
COIN
BTCUSD
Bitcoin
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
DBI
MDAX
MDAX
COIN
ADAUSD
Cardano
NYSE
JPM
JP Morgan Chase
CCOM
US500
US 500
DBI
SDXP
SDAX
TG
RHM
Rheinmetall
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten